David F Kronn MD
Medical Genetics
Associate Professor, Pediatrics, New York Medical College
Join to view full profile
Regional Medical Genetics503 Grasslands Road Suite 200Valhalla, NY 10595
Phone+1 914-304-5280
Fax+1 914-345-1753
Dr. Kronn is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Pediatrics, 1990 - 1996
University of Dublin Trinity CollegeClass of 1989
Certifications & Licensure
NY State Medical License 1993 - 2027
CT State Medical License 1998 - 2025
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors Castle Connolly, 2012-2014
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
Clinical Trials
Publications & Presentations
PubMed
- Evaluation of electrical impedance myography as a noninvasive musculoskeletal biomarker in infantile- and late-onset Pompe disease.Raquel van Gool, Nehal Shah, Amanda Cao, Lise Vrolix, Buket Sonbas Cobb
Genetics in Medicine. 2026-09-01 - 4 citationsEarly initiation of enzyme replacement therapy as facilitated by newborn screening improves health outcomes among patients with infantile-onset Pompe disease.Ankit K Desai, Eleanor Rodriguez-Rassi, Suhag Parikh, Rossana Sanchez Russo, David Kronn
Genetics in Medicine Open. 2026-01-01 - 3 citationsThe Mini-COMET Clinical Trial: Safety and Efficacy of Avalglucosidase Alfa after 97 Weeks of Treatment in Children with Infantile-Onset Pompe Disease Previously Treate...David Kronn, James Davison, Alexander Broomfield, Anaïs Brassier, François Labarthe
The Journal of Pediatrics. 2025-10-01
Press Mentions
Sanofi’s Next-Generation ERT Halts Progression of Pompe Disease in Patients, Interim Trial Data ShowFebruary 13th, 2020
High Prices for Orphan Drugs Strain Families and InsurersJanuary 17th, 2017- Sky-High Prices for Orphan Drugs Slam American Families and InsurersJanuary 17th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
